Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts

Dedee F. Murrell; Branka Marinovic; Frederic Caux; Catherine Prost; Razzaque Ahmed; Katarzyna Wozniak; Masayuki Amagai; Johann Bauer; Stefan Beissert; Luca Borradori; Donna Culton; Janet A. Fairley; David Fivenson; Marcel F. Jonkman; M. Peter Marinkovich; David Woodley; John Zone; Valeria Aoki; Philippe Bernard; Leen Bruckner-Tuderman; Giuseppe Cianchini; Vanessa Venning; Luis Diaz; Rudiger Eming; Sergei A. Grando; Russell P. Hall; Takashi Hashimoto; Josep E. Herrero-González; Michael Hertl; Pascal Joly; Sarolta Karpati; Jaehwan Kim; Soo Chan Kim; Neil J. Korman; Cezary Kowalewski; Sang Eun Lee; David R. Rubenstein; Eli Sprecher; Kim Yancey; Giovann Zambruno; Detlef Zillikens; Serge Doan; Benjamin S. Daniel; Victoria P. Werth

doi:10.1016/j.jaad.2014.08.024

Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts

Dedee F. Murrell^*
, Branka Marinovic
, Frederic Caux
, Catherine Prost
, Razzaque Ahmed
, Katarzyna Wozniak
, Masayuki Amagai
, Johann Bauer
, Stefan Beissert
, Luca Borradori
, Donna Culton
, Janet A. Fairley
, David Fivenson
, Marcel F. Jonkman
, M. Peter Marinkovich
, David Woodley
, John Zone
, Valeria Aoki
, Philippe Bernard
, Leen Bruckner-Tuderman

Giuseppe Cianchini, Vanessa Venning, Luis Diaz, Rudiger Eming, Sergei A. Grando, Russell P. Hall, Takashi Hashimoto, Josep E. Herrero-González, Michael Hertl, Pascal Joly, Sarolta Karpati, Jaehwan Kim, Soo Chan Kim, Neil J. Korman, Cezary Kowalewski, Sang Eun Lee, David R. Rubenstein, Eli Sprecher, Kim Yancey, Giovann Zambruno, Detlef Zillikens, Serge Doan, Benjamin S. Daniel, Victoria P. Werth

^*Corresponding author for this work

Department of Dermatology, Allergology and Venereology

Macquarie University, Australian School of Advanced Medicine
University of Zagreb
University of Paris XIII
Department of Dermetology
Center for Blistering Diseases
Department of Dermatology and Immunodermatology
Medical University of Warsaw
Keio University School of Medicine
Division of Molecular Dermatology
Paracelsus Medical University
Technische Universität Dresden
University of Bern
University of North Carolina
University of Iowa
VA Medical Center
St Joseph Mercy Health System
University of Groningen
Stanford University
Department of Veterans Affairs Palo Alto Healthcare System
Keck School of Medicine of USC
University of Utah
University of Sao Paulo
Reims University Hospital
Dokumentationszentrum Schwerer Hautreaktionen
University of Freiburg
Immunodermatology Department
IRCCS Istituto Dermopatico dell'Immacolata - Roma
Laboratory of Molecular and Cell Biology
Churchill Hospital
University of Marburg
University of California, Irvine
Research Institute
Duke University
Kurume University School of Medicine
Hospital del Mar
University of Rouen
Semmelweis University
Laboratory for Investigative Dermatology
Rockefeller University
Department of Dermatology and Cutaneous Biology Research Institute
Yonsei University College of Medicine
Department of Dermatology and the Murdough Family Center for Psoriasis
University Hospitals Case Medical Center
CHA University
Tel-Aviv University
University of Texas Southwestern
Department of Ophthalmology
Hôpital Bichat
Fondation A de Rothschild
Philadelphia Department of Veterans Affairs Medical Center
University of Pennsylvania

143 Citations (Scopus)

Abstract

Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.

Original language	English
Journal	Journal of the American Academy of Dermatology
Volume	72
Issue number	1
Pages (from-to)	168-174
Number of pages	7
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2014.08.024
Publication status	Published - 01.01.2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jaad.2014.08.024

Cite this

Murrell, D. F., Marinovic, B., Caux, F., Prost, C., Ahmed, R., Wozniak, K., Amagai, M., Bauer, J., Beissert, S., Borradori, L., Culton, D., Fairley, J. A., Fivenson, D., Jonkman, M. F., Marinkovich, M. P., Woodley, D., Zone, J., Aoki, V., Bernard, P., ... Werth, V. P. (2015). Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts. Journal of the American Academy of Dermatology, 72(1), 168-174. https://doi.org/10.1016/j.jaad.2014.08.024

@article{c2df6ef184de4a1099186df3b9a9237b,

title = "Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts",

abstract = "Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.",

author = "Murrell, \{Dedee F.\} and Branka Marinovic and Frederic Caux and Catherine Prost and Razzaque Ahmed and Katarzyna Wozniak and Masayuki Amagai and Johann Bauer and Stefan Beissert and Luca Borradori and Donna Culton and Fairley, \{Janet A.\} and David Fivenson and Jonkman, \{Marcel F.\} and Marinkovich, \{M. Peter\} and David Woodley and John Zone and Valeria Aoki and Philippe Bernard and Leen Bruckner-Tuderman and Giuseppe Cianchini and Vanessa Venning and Luis Diaz and Rudiger Eming and Grando, \{Sergei A.\} and Hall, \{Russell P.\} and Takashi Hashimoto and Herrero-Gonz{\'a}lez, \{Josep E.\} and Michael Hertl and Pascal Joly and Sarolta Karpati and Jaehwan Kim and \{Chan Kim\}, Soo and Korman, \{Neil J.\} and Cezary Kowalewski and Lee, \{Sang Eun\} and Rubenstein, \{David R.\} and Eli Sprecher and Kim Yancey and Giovann Zambruno and Detlef Zillikens and Serge Doan and Daniel, \{Benjamin S.\} and Werth, \{Victoria P.\}",

year = "2015",

month = jan,

day = "1",

doi = "10.1016/j.jaad.2014.08.024",

language = "English",

volume = "72",

pages = "168--174",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "1",

}

Murrell, DF, Marinovic, B, Caux, F, Prost, C, Ahmed, R, Wozniak, K, Amagai, M, Bauer, J, Beissert, S, Borradori, L, Culton, D, Fairley, JA, Fivenson, D, Jonkman, MF, Marinkovich, MP, Woodley, D, Zone, J, Aoki, V, Bernard, P, Bruckner-Tuderman, L, Cianchini, G, Venning, V, Diaz, L, Eming, R, Grando, SA, Hall, RP, Hashimoto, T, Herrero-González, JE, Hertl, M, Joly, P, Karpati, S, Kim, J, Chan Kim, S, Korman, NJ, Kowalewski, C, Lee, SE, Rubenstein, DR, Sprecher, E, Yancey, K, Zambruno, G, Zillikens, D, Doan, S, Daniel, BS & Werth, VP 2015, 'Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts', Journal of the American Academy of Dermatology, vol. 72, no. 1, pp. 168-174. https://doi.org/10.1016/j.jaad.2014.08.024

TY - JOUR

T1 - Definitions and outcome measures for mucous membrane pemphigoid

T2 - Recommendations of an international panel of experts

AU - Murrell, Dedee F.

AU - Marinovic, Branka

AU - Caux, Frederic

AU - Prost, Catherine

AU - Ahmed, Razzaque

AU - Wozniak, Katarzyna

AU - Amagai, Masayuki

AU - Bauer, Johann

AU - Beissert, Stefan

AU - Borradori, Luca

AU - Culton, Donna

AU - Fairley, Janet A.

AU - Fivenson, David

AU - Jonkman, Marcel F.

AU - Marinkovich, M. Peter

AU - Woodley, David

AU - Zone, John

AU - Aoki, Valeria

AU - Bernard, Philippe

AU - Bruckner-Tuderman, Leen

AU - Cianchini, Giuseppe

AU - Venning, Vanessa

AU - Diaz, Luis

AU - Eming, Rudiger

AU - Grando, Sergei A.

AU - Hall, Russell P.

AU - Hashimoto, Takashi

AU - Herrero-González, Josep E.

AU - Hertl, Michael

AU - Joly, Pascal

AU - Karpati, Sarolta

AU - Kim, Jaehwan

AU - Chan Kim, Soo

AU - Korman, Neil J.

AU - Kowalewski, Cezary

AU - Lee, Sang Eun

AU - Rubenstein, David R.

AU - Sprecher, Eli

AU - Yancey, Kim

AU - Zambruno, Giovann

AU - Zillikens, Detlef

AU - Doan, Serge

AU - Daniel, Benjamin S.

AU - Werth, Victoria P.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.

AB - Mucous membrane pemphigoid encompasses a group of autoimmune bullous diseases with a similar phenotype characterized by subepithelial blisters, erosions, and scarring of mucous membranes, skin, or both. Although knowledge about autoimmune bullous disease is increasing, there is often a lack of clear definitions of disease, outcome measures, and therapeutic end points. With clearer definitions and outcome measures, it is possible to directly compare the results and data from various studies using meta-analyses. This consensus statement provides accurate and reproducible definitions for disease extent, activity, outcome measures, end points, and therapeutic response for mucous membrane pemphigoid and proposes a disease extent score, the Mucous Membrane Pemphigoid Disease Area Index.

UR - https://www.scopus.com/pages/publications/84917671759

U2 - 10.1016/j.jaad.2014.08.024

DO - 10.1016/j.jaad.2014.08.024

M3 - Scientific review articles

C2 - 25443626

AN - SCOPUS:84917671759

SN - 0190-9622

VL - 72

SP - 168

EP - 174

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 1

ER -

Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this